PharmaTest ELISA Kits

Explore Our Comprehensive Range of Pharmacokinetic and Immunogenicity ELISA Kits

Our extensive catalog of ELISA kits is designed to meet the diverse needs of researchers studying the pharmacokinetics and immunogenicity of therapeutic antibodies and other biologics. These high-quality kits provide reliable and reproducible results, allowing researchers to monitor drug levels, assess anti-drug antibody responses, and ensure therapeutic efficacy in preclinical and clinical settings.

Each ELISA kit in this collection is tailored to specific biotherapeutics, such as Natalizumab (Tysabri), Omalizumab (Xolair), Tocilizumab (Actemra), Adalimumab (Humira), and more, with assays optimized for detecting drug concentration, anti-drug antibody responses, or neutralizing activity. These assays feature:

• Wide Detection Ranges: Offering sensitivity from as low as 0.78 ng/mL, ensuring accurate measurement across a broad concentration spectrum.
• Reactivity: Specific to human or mouse samples, making these kits suitable for various species and experimental needs.
• Sample Type Compatibility: Optimized for serum samples, the standard in pharmacokinetic and immunogenicity research.
• Rapid and Efficient Protocols: Assays are designed to yield results in 2.5 to 3.5 hours, maximizing lab efficiency without compromising accuracy.
• Various Assay Formats: Direct, competitive, and bridging assays are available, tailored to the unique requirements of pharmacokinetic and immunogenicity studies.

Whether you’re monitoring therapeutic antibody levels, detecting anti-drug antibodies, or studying neutralizing antibodies in response to SARS-CoV-2, our ELISA kits deliver dependable data to support critical research in drug development, personalized medicine, and immune response analysis. With consistent results and comprehensive support, these kits are invaluable tools for scientists striving to advance therapeutic innovation.